Thomas Bainton

Thomas Bainton

Auto-generated profile, based on publicly available information

Thomas Bainton

Chelsea and Westminster Hospital London UK

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2021 in Placenta
Verified
Journal Article
Closed access
AMAlexandros A. Moraitis
Alexandros A. Moraitis
TBThomas Bainton
Thomas Bainton
USUlla Sovio
Ulla Sovio
PBPeter Brocklehurst
Peter Brocklehurst
AHAlexander Ep. Heazell
Alexander Ep. Heazell
GSGordon Cs. Smith
Gordon Cs. Smith

10 August 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
ACAntonia O. Cuff
Antonia O. Cuff
EWEe Von Woon
Ee Von Woon
TBThomas Bainton
Thomas Bainton
BBBrendan Browne
Brendan Browne
PKPhoebe M. Kirkwood
Phoebe M. Kirkwood
Victoria MaleVictoria Male
Victoria Male
Innate lymphoid cells (ILC) are prominent in the human uterine mucosa and play physiological roles in pregnancy. ILC3 are the second-most common ILC subset in the uterine mucosa, but their role remains unclear. Here we define two subsets of lineage-negative CD56+ CD117+ CRTH2-uterine ILC3, distinguished by their expression of CD127. The CD127-subset is most numerous and active during menstruation and immediately after parturition, suggesting a role in repair of the uterine mucosa (called endometrium outside of pregnancy); the CD127+ subset is most numerous and active immediately after menstruation, as the endometrium regenerates. In healthy endometrium, ILC3 are spatially associated with glandular epithelial and endothelial cells, which both express receptors for the ILC3-derived cytokines, IL-22 and IL-8. In the eutopic endometrium of people with endometriosis, ILC3 are located further from glandular epithelial and endothelial cells suggesting that these cells may be less exposed to ILC3 products, potentially with negative consequences for endometrial regeneration. Our findings highlight the dynamic nature of ILC3 in the uterine mucosa and suggest their primary role is in repair and regeneration. An improved understanding of uterine ILC3 will inform future research on endometrial health and disease.

20 November 2022 in Colorectal Disease
Verified
Journal Article
Closed access
TGThomas N Grove
Thomas N Grove
TBThomas Bainton
Thomas Bainton
VCValerio Celentano
Valerio Celentano
ARAmer Raza
Amer Raza
OWOliver Warren
Oliver Warren

16 May 2021 in Colorectal Disease
Verified
Journal Article
Closed access
PDF file
TBThomas Bainton
Thomas Bainton
VCValerio Celentano
Valerio Celentano
JPJames Phillips
James Phillips
OWOliver Warren
Oliver Warren
RRRicharson Richardson
Richarson Richardson
ARAmer Raza
Amer Raza

26 October 2022
Verified
Preprint
Open access
PDF file
TBThomas Bainton
Thomas Bainton
SJSobanakumari Jeyapala
Sobanakumari Jeyapala
JZJavier Zamora
Javier Zamora
Khalid KhanKhalid Khan
Khalid Khan
ARAmer Raza
Amer Raza
Background: Endometriosis is a chronic, often debilitating condition with a current significant delay from symptom onset to diagnosis. Objectives: To investigate the accuracy of symptoms, clinical history and non-invasive tests to predict pelvic endometriosis. Data sources: Medline, Embase, Web of Science and Scopus from conception to September 2022. Selection criteria: Primary test accuracy studies assessing selected non-invasive tests against a reference standard diagnosis for endometriosis. Data extraction and synthesis: Two authors independently conducted data extraction and study quality assessment. Grading of evidence was performed using a novel visual pentagon model. Meta-analyses of test accuracy was estimated using bivariate random effects models. Results: The 125 included studies (250,574 participants) showed mixed quality. Studies applying non-surgical (database/self-reporting) reference standard had a greater risk of bias. In 98 studies applying surgical reference standard, summary diagnostic odds ratios were: dysmenorrhoea 2.56 (95% confidence interval 1.99-3.29); pelvic pain 2.56 (1.73-3.74); dyschezia 2.05 (1.36-3.10); dyspareunia 2.45 (1.71-3.52); family history of endometriosis 6.79 (4.08-11.3); nulligravidity of 2.01 (1.62-2.50); BMI ≥30kg/m2 0.37 (0.19-0.68); TVUSS endometrioma 91.2 (44.0-189); TVUSS invasive endometriosis 26.1 (9.28-73.5); and CA-125 >35U/mL 16.0 (8.09-31.7). Sensitivity analysis excluding all high-risk studies found concordant results. Conclusions: This meta-analysis collated the performance of non-invasive tests for endometriosis across a comprehensive and geographically varied population. Study quality was mixed, however results were consistent with high-risk studies excluded. These findings will inform future prediction models for triage in primary care. Funding: This research received no specific funding. Keywords: Endometriosis; diagnosis; laparoscopy; pelvic pain; sub-fertility